Glutamine
Post Acute Covid-19 Vaccination Syndrome
Independent Medical AllianceSmall moleculePhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Post Acute Covid-19 Vaccination Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ARG Independent Medical Alliance | Phase 2 | CCC |
N-Acetyl-L-Cysteine Independent Medical Alliance | Phase 2 | CCC |
L-Citrulline Independent Medical Alliance | Phase 2 | CCC |
L-Serine Independent Medical Alliance | Phase 2 | CCC |
Same molecule, other indications
Glutamine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →